Most Popular

Innovation

The new fluoride? FDA greenlights rapamycin oral health trial

Trial to evaluate rapamycin in periodontal disease gets FDA go-ahead – Matt Kaeberlein’s Optispan to monitor aging biomarkers.

Stanford organ aging study spawns new longevity startup

Biotech company Teal Omics founded after researchers develop algorithm that measures how fast individual organs are aging.

Hevolution pumps another $40 million into aging research projects

Aging research organizations including the Buck and AFAR benefit as Global Healthspan Summit funding commitments reach $100m.

Could XPRIZE Healthspan deliver the ‘holy grail’ for longevity science?

XPRIZE exec director Dr Jamie Justice on how the $101m competition can deliver a lasting legacy to the longevity field.

Supplements

Editor's pick

Investment

Interface Bio emerges with $3m to harness the microbiome against inflammation

AI-powered platform identifies bacterial natural products with the potential to modulate the immune system and reduce inflammation.

Biolexis lands $10m to advance metabolic drug program with longevity potential

AI-powered drug discovery company is developing metabolic drug candidates targeting obesity, diabetes and human longevity.

Hevolution pumps another $40 million into aging research projects

Aging research organizations including the Buck and AFAR benefit as Global Healthspan Summit funding commitments reach $100m.

XPRIZE Healthspan offers $101m prize for successful longevity therapeutic

Winners will need to demonstrate their longevity therapy can restore muscle, cognition, and immune function by up to 20 years.

Watch now

Agetech

Physicians want AI tech to help dementia patients live longer

Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.

Connected technologies are changing the future of aging at home

Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.

AI innovations to transform living with dementia awarded £1.9 million

Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.

Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech

Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.

AI/Digital